Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Awareness Regarding Clinical Trials Among Patients with Multiple Myeloma (MM): A Systematic Study to Validate Online Platforms for Conducting Patient Surveys

Jay R. Hydren, Mason S. Barnes, Rachel M Jensen, Leyla Bojanini, Dhaani Ailawadhi, Saurav Das, Jennifer M. Ahlstrom, Sikander Ailawadhi

Blood (2024) 144 (Supplement 1): 7620.

https://doi.org/10.1182/blood-2024-203280

Published: 2024

Journal Articles

Speeding up Myeloma Care: Robust Machine Learning Predictions of M-Spike Levels

Ehsan Malek, Juan Pablo Capdevila, Jennifer M. Ahlstrom, Jorge Arturo Hurtado Martinez, Gi-Ming Wang, Jay R. Hydren, James J. Driscoll, II

Blood (2024) 144 (Supplement 1): 7604.

https://doi.org/10.1182/blood-2024-200888

Published: 2024

Journal Articles

Machine Learning in Myeloma: Do Racial Differences Influences Systemic Impact of Multiple Myeloma?

Hector Tirado, Jorge Arturo Hurtado Martinez, Jennifer M. Ahlstrom, Jay R. Hydren, Juan Pablo Capdevila, James J. Driscoll, II, Gi-Ming Wang, Ehsan Malek

Blood (2024) 144 (Supplement 1): 7840.

https://doi.org/10.1182/blood-2024-208026

Published: 2024

Journal Articles

Dexamethasone Is Associated with Cataracts in Multiple Myeloma Even after Adjusting for Age: Results of a Large Cross-Sectional Survey

Rahul Banerjee, Jorge Arturo Hurtado Martinez, Mason S. Barnes, Patricia Alejandra Flores Pérez, Jay R. Hydren, Jennifer M. Ahlstrom, Kara I. Cicero, Gurbakhash Kaur, Parisa Taravati, Andrew J. Cowan

Blood (2024) 144 (Supplement 1): 7828.

https://doi.org/10.1182/blood-2024-201803

Published: 2024

Journal Articles

Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma

Jorge Arturo Hurtado Martinez, Felipe Flores Quiroz, Jennifer M. Ahlstrom, Rafael Fonseca, Julie R. Strain, Laura Iadeluca, Rachel M Jensen, Cynthia Chmielewski, Saad Z. Usmani, Jay R. Hydren

Blood (2024) 144 (Supplement 1): 706.

https://doi.org/10.1182/blood-2024-208847

Published: 2024

Journal Articles

National Healthtree Survey on Pain and Opioid Use Patterns and Perceptions Among Patients with Multiple Myeloma

Karen Sweiss, Jay R. Hydren, Jorge Arturo Hurtado Martinez, Mason S. Barnes, Pritesh Patel, Douglas W Sborov, Jennifer M. Ahlstrom, Lisa Sharp, Craig C. Hofmeister

Blood (2024) 144 (Supplement 1): 283.

https://doi.org/10.1182/blood-2024-210314

Published: 2024

Journal Articles

First Ever National Survey on Patient-Reported Efficacy and Safety of Cannabis in Patients with Multiple Myeloma

Karen Sweiss, Jay R. Hydren, Jorge Arturo Hurtado Martinez, Mason S. Barnes, Pritesh Patel, Douglas W. Sborov, Jennifer M. Ahlstrom, Lisa Sharp, Craig C. Hofmeister

Blood (2024) 144 (Supplement 1): 5144.

https://doi.org/10.1182/blood-2024-210437

Published: 2024

Journal Articles

AL Amyloidosis: Understanding the Clinical Prodrome and Delays in Diagnosis

Nadine Abdallah, Jay R. Hydren, Mason S. Barnes, Andrew Wood, Sascha Alexander Tuchman, Jeffrey A. Zonder, Giada Bianchi, Heather J. Landau, Muhamed Baljevic, James E. Hoffman, Ana M. Sahagun Sanchez Aldana, Jorge Arturo Hurtado Martinez, Jennifer M. Ahlstrom, Morie A. Gertz

Blood (2024) 144 (Supplement 1): 5143.

https://doi.org/10.1182/blood-2024-208737

Published: 2024

Journal Articles

Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey

Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger, Ryan Winborg, Mason S. Barnes, Jorge Arturo Hurtado Martinez, Jay R. Hydren, Douglas W Sborov, Amandeep Godara, Brian McClune, Christopher Booth, Edward R Scheffer Cliff

Blood (2024) 144 (Supplement 1): 2281.

https://doi.org/10.1182/blood-2024-208803

Published: 2024

Journal Articles

Satisfaction and Experiences with Talquetamab: Results from Qualitative Patient and Physician Research

Beth M. Faiman, Cesar Rodriguez, Smith Giri, Christine Brittle, Jay R. Hydren, Karla Mariana Castro Bórquez, Maria Gambill, Ana M. Sahagun Sanchez Aldana, Jennifer M. Ahlstrom, Hoa H. Le, Saurabh N. Patel, Kathleen S Gray, Xinke Zhang, Rafael Fonseca

Blood (2024) 144 (Supplement 1): 3786.

https://doi.org/10.1182/blood-2024-207403

Published: 2024

Journal Articles

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Blood (2024) 144 (4): 359–367.

https://doi.org/10.1182/blood.2024024371

Published: 2024

Includes: Supplemental data

Journal Articles

Age-Based Comparison of Stem Cell Transplantation during the First Line of Therapy for Multiple Myeloma Patients

Jorge Arturo Arturo Hurtado Martinez, Jay R. Hydren, Patricia Alejandra Flores Pérez, Mason S. Barnes, Felipe Flores Quiroz, Nathan Sweeney, Karla Mariana Castro Bórquez, Andrea Isabel Robles Espinoza, Jennifer M. Ahlstrom

Blood (2023) 142 (Supplement 1): 3598.

https://doi.org/10.1182/blood-2023-189796

Published: 2023

Journal Articles

Dietary Patterns Among Individuals with Plasma Cell Disorders Compared to the General US Population

Kadiatou Traore, Alankrita Taneja, Elan Gorshein, Francesca Castro, Andriy Derkach, Jorge Arturo Hurtado Martinez, Edith Serrano, Alexander Lesokhin, Jennifer M. Ahlstrom, Torin Block, Jay R. Hydren, Saad Z Usmani, Urvi A Shah

Blood (2023) 142 (Supplement 1): 7363.

https://doi.org/10.1182/blood-2023-186913

Published: 2023

Journal Articles

Multiple Myeloma Patient Perceptions of Minimal Residual Disease Testing

Jay R. Hydren, Felipe Flores Quiroz, Patricia Alejandra Flores Pérez, Jorge Arturo Arturo Hurtado Martinez, Karla Mariana Castro Bórquez, Andrea Jimena Cuevas Vicencio, Andrea Isabel Robles Espinoza, Marilú Nájera Flores, Eduardo Franco Hernandez, Ana M. Sahagun Sanchez Aldana, Jennifer M. Ahlstrom

Blood (2023) 142 (Supplement 1): 2410.

https://doi.org/10.1182/blood-2023-190364

Published: 2023

Journal Articles

Age-Based Comparison of Dara-Rvd, Krd and Rvd Induction Therapies during the First Line of Therapy for Multiple Myeloma Patients

Jennifer M. Ahlstrom, Patricia Alejandra Flores Pérez, Felipe Flores Quiroz, Karla Mariana Castro Bórquez, Mason S. Barnes, Jay R. Hydren, Jorge Arturo Arturo Hurtado Martinez

Blood (2023) 142 (Supplement 1): 6703.

https://doi.org/10.1182/blood-2023-190483

Published: 2023

Journal Articles

Unraveling the Dynamics of Protein Secretion in Multiple Myeloma: A Comparative Study of Non-Secretory Patterns and Disease Evolution

Jorge Arturo Arturo Hurtado Martinez, Patricia Alejandra Flores Pérez, Felipe Flores Quiroz, Karla Mariana Castro Bórquez, Nathan Sweeney, Christian Cheung, Andrea Isabel Robles Espinoza, Andrea Jimena Cuevas Vicencio, Eduardo Franco Hernandez, Marilú Nájera Flores, Ana M. Sahagun Sanchez Aldana, Jennifer M. Ahlstrom, Jay R. Hydren

Blood (2023) 142 (Supplement 1): 6704.

https://doi.org/10.1182/blood-2023-190557

Published: 2023

Journal Articles

A Retrospective Comparison of the Side Effect Prevalence and Severity of Multiple Myeloma Triplet Vs Quadruplet Induction Therapy

Nathan W. Sweeney, Emily W. Ballard, Eduardo Franco Hernandez, Andrea Isabel Robles Espinoza, Andrea Jimena Cuevas Vicencio, Patricia Alejandra Flores Pérez, Thomas H. Molina, Jennifer M. Ahlstrom, Jay R. Hydren

Blood (2022) 140 (Supplement 1): 7178–7179.

https://doi.org/10.1182/blood-2022-170392

Published: 2022

Journal Articles

What Are the Top Myeloma Patient Concerns at and Since Diagnosis?

Jennifer M. Ahlstrom, Nathan W. Sweeney, David F. Barton, Jorge Arturo Hurtado Hurtado Martinez, Jay R. Hydren

Blood (2022) 140 (Supplement 1): 13105.

https://doi.org/10.1182/blood-2022-170557

Published: 2022

Journal Articles

The Top Concerns at and Since Diagnosis: Standard v. High Risk Myeloma Patients

Jorge Arturo Hurtado Hurtado Martinez, Nathan W. Sweeney, David F. Barton, Jennifer M. Ahlstrom, Jay R. Hydren

Blood (2022) 140 (Supplement 1): 10940–10941.

https://doi.org/10.1182/blood-2022-171031

Published: 2022

Journal Articles

The Relationship between Therapeutic Pressure and Multiple Myeloma Risk Stratification: A 5 Year Real-World-Data Analysis

Jay R. Hydren, Jorge Arturo Hurtado Hurtado Martinez, Ana Sahagun, Christian S. Cheung, Eduardo Franco Hernandez, Patricia Alejandra Flores Pérez, Felipe Flores Quiroz, Marilú Nájera Flores, Andrea Isabel Robles Espinoza, Andrea Jimena Cuevas Vicencio, Thomas H. Molina, Jennifer M. Ahlstrom, Nathan W. Sweeney

Blood (2022) 140 (Supplement 1): 12583–12584.

https://doi.org/10.1182/blood-2022-170388

Published: 2022

NARROW

Awareness Regarding Clinical Trials Among Patients with Multiple Myeloma (MM): A Systematic Study to Validate Online Platforms for Conducting Patient Surveys

Speeding up Myeloma Care: Robust Machine Learning Predictions of M-Spike Levels

Machine Learning in Myeloma: Do Racial Differences Influences Systemic Impact of Multiple Myeloma?

Dexamethasone Is Associated with Cataracts in Multiple Myeloma Even after Adjusting for Age: Results of a Large Cross-Sectional Survey

Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma

National Healthtree Survey on Pain and Opioid Use Patterns and Perceptions Among Patients with Multiple Myeloma

First Ever National Survey on Patient-Reported Efficacy and Safety of Cannabis in Patients with Multiple Myeloma

AL Amyloidosis: Understanding the Clinical Prodrome and Delays in Diagnosis

Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey

Satisfaction and Experiences with Talquetamab: Results from Qualitative Patient and Physician Research

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Age-Based Comparison of Stem Cell Transplantation during the First Line of Therapy for Multiple Myeloma Patients

Dietary Patterns Among Individuals with Plasma Cell Disorders Compared to the General US Population

Multiple Myeloma Patient Perceptions of Minimal Residual Disease Testing

Age-Based Comparison of Dara-Rvd, Krd and Rvd Induction Therapies during the First Line of Therapy for Multiple Myeloma Patients

Unraveling the Dynamics of Protein Secretion in Multiple Myeloma: A Comparative Study of Non-Secretory Patterns and Disease Evolution

A Retrospective Comparison of the Side Effect Prevalence and Severity of Multiple Myeloma Triplet Vs Quadruplet Induction Therapy

What Are the Top Myeloma Patient Concerns at and Since Diagnosis?

The Top Concerns at and Since Diagnosis: Standard v. High Risk Myeloma Patients

The Relationship between Therapeutic Pressure and Multiple Myeloma Risk Stratification: A 5 Year Real-World-Data Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only